NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 270 filers reported holding NOVOCURE LTD in Q1 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $15,213,000 | +17.0% | 87,918 | -24.8% | 0.54% | +9.9% |
| Q3 2020 | $13,006,000 | +66.6% | 116,845 | -11.2% | 0.49% | +64.0% |
| Q2 2020 | $7,806,000 | +7.9% | 131,637 | +22.5% | 0.30% | -9.2% |
| Q1 2020 | $7,235,000 | -20.1% | 107,438 | 0.0% | 0.33% | -4.4% |
| Q4 2019 | $9,054,000 | +20.0% | 107,438 | +6.4% | 0.34% | +4.0% |
| Q3 2019 | $7,548,000 | +120.8% | 100,932 | +86.7% | 0.33% | +135.0% |
| Q2 2019 | $3,419,000 | +7.6% | 54,074 | -18.0% | 0.14% | +8.5% |
| Q1 2019 | $3,177,000 | +287.4% | 65,964 | +169.2% | 0.13% | +268.6% |
| Q4 2018 | $820,000 | – | 24,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
| Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
| HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
| GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
| Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
| HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
| HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
| Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |